Add BrightSurf on Google Email

Science News for July 22, 2012


Embargoed news from Annals of Internal Medicine

The FDA Antiviral Advisory Committee discusses the pros and cons of Truvada approval for pre-exposure prophylaxis (PrEP). Dr. Judith Feinberg votes in favor of approval, citing good outcomes and tolerability, while Dr. Lauren V. Wood expresses concerns about inconsistent evidence, adherence issues, and safety concerns. Primary care phy...

SourceAmerican College of Physicians·JournalAnnals of Internal Medicine·DateJul 22, 2012

Working toward an AIDS-free generation

A multifaceted global effort could lead to an AIDS-free generation by expanding testing, treatment, and prevention programs. Combination antiretroviral therapy has significantly improved health and longevity for individuals infected with HIV, saving an estimated 700,000 lives globally in 2010.

SourceJAMA Network·JournalJAMA·DateJul 22, 2012